Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin
- PMID: 36502864
- PMCID: PMC10786320
- DOI: 10.1053/j.gastro.2022.11.047
Impact of Helicobacter pylori Eradication on Incidence of Peptic Ulcer Bleeding in Patients Taking Regular Aspirin
Conflict of interest statement
Conflicts of interest
The author discloses the following: Medtronic (consulting), Ironwood Pharmaceuticals (consulting; research support), Phathom Pharmaceuticals (consultant; institutional), StatLinkMD (consulting), Medscape (consulting); RJS Mediagnostix (advisory board with stock).
Comment on
-
Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.Lancet. 2022 Nov 5;400(10363):1597-1606. doi: 10.1016/S0140-6736(22)01843-8. Lancet. 2022. PMID: 36335970 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical